Endoskeleton Implant for Lumbar Fusion by Titan Spine Backed by Clinical Data

Written by Heather Linder | April 15, 2013 | Print  |

Titan Spine released clinical data at the 13th Annual Meeting of the International Society for the Advancement of Spine Surgery that supports the use of its Endoskeleton titanium interbody cage for lumbar fusion.

The prospective study looked at 77 patients undergoing ALIF procedures with the device. Independent radiologists analyzed the 138 spine segment levels treated, and found a 100 percent fusion rate between 6 and 12 months, according to the release.

The Endoskeleton implant uses a proprietary acid-etched surface to support bone purchase and new bone growth.

More Articles on Supply Chain:
Medtronic to Recruit 323 Patients for Back Pain Treatment Clinical Trial
Medical Device Purchase: 3 Statistics on Physician Influence
FDA Increases Stryker Knee Device Recall to Class 1

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.